Artificial Intelligence in the Pharmaceutical Industry
The pharmaceutical development process is notoriously complex and comprises many different phases from discovery to market access.
Stevanato Group provides containment, delivery and diagnostic solutions for pharmaceutical applications.
You have successfully submitted your enquiry. Someone from our company will respond ASAP
Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and life sciences industries.
We deliver an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug lifecycle, from development to commercial stages.
Our core capabilities in scientific research and development (R&D), commitment to technical innovation and engineering excellence are central to our ability to offer value-added solutions to clients.
With more than 70 years’ experience in producing advanced glass containers for the biopharmaceutical industry, Stevanato Group offers drug containment solutions, plastic solutions and drug delivery systems.
We provide a range of products tailored to specific biopharmaceutical requirements and can also offer support for plastic products.
Our experts are specialists in multi-component injection moulding and automated system assembly. As a one-stop solution provider and manufacturer, we can cover all parts of the product development process, packaging and sterilising as needed.
We combine our knowledge to offer integrated solutions, from early development to launched combination products. Our core and extended drug delivery systems teams will work closely with your staff and consulting experts to help you successfully market your drug product in a device that suits your patients’ needs.
Stevanato Group provides three pillars of technologies and manufacturing, namely visual inspection, assembly equipment and secondary packaging.
Using our wide portfolio and extensive inspection expertise, we deliver flexible assessment solutions at all stages of the product lifecycle, from the laboratory to high-volume production, for a broad range of applications.
We design, develop and manufacture high-yield assembly lines for medical devices such as auto-injectors, pen injectors and inhalers, to develop customised solutions. A focus on robotics, quick-format change and gentle handling ensure highly reliable and efficient production.
Stevanato Group can also provide secondary packaging lines that can be adapted to different volumes for multiple product formats, including primary glass containers and drug delivery devices.
As part of Stevanato Group’s commitment to R&D, our analytical testing facilities focus on investigating the physico-chemical properties of primary packaging materials and components, as well as studying the interactions between container closure systems and drugs.
We rely on a multi-disciplinary team of highly skilled professionals, including scientists, engineers, pharmaceutical chemists and biotechnologists. Their knowledge and experience cover a range of specialised areas, from container closure systems to drug delivery devices.
Founded in 1949, Stevanato Group’s aim is to make a difference in the pharmaceutical and healthcare industries.
We have a presence in nine countries and operate nine plants for pharmaceutical and healthcare products, five plants for high–quality technologies, and two sites for analytical services.
The pharmaceutical development process is notoriously complex and comprises many different phases from discovery to market access.
Company to receive $95m to expand vial production in the United States
The Aidaptus® disposable auto-injector platform, designed by Owen Mumford, will be jointly offered to global biopharma companies to support their drug development programs with engineering and manufacturing support provided by Stevanato Group.
Italian-based Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, and Bexson Biomedical, a research stage company developing subcutaneous therapies for pain management and mental health disorders, announced today that they have signed an agreement expanding their collaboration.
The glass container traceability solution marks each primary container with a unique identity. If a problem is identified during a process step, manufacturers can define exactly which products may have been impacted.
Our containers are designed to simplify the selection process of our customers regardless of the complexity of the drug. SG Nexa® offers superior quality and performances for the most demanding drugs.
The Vision Robot Unit (VRU) is a new generation of inspection machines with world-class performance. Vision Robot Unit is a robotic human-like inspection unit engineered to deliver optimized inspection performances – and ready to integrate Deep Learning models.
We can support our customers in streamlining their manufacturing process, thanks to our expertise in assembling and packaging drug delivery devices and pharmaceutical products. We design and manufacture flexible standalone or turnkey integrated systems to deal with different requirements and support the partners from the first stage to commercialization.
Our mission is to provide analytical services to enhance the integrity of parenteral medicines, producing the leading edge in scientific and technological expertise for Stevanato Group and its customers. We offer a wide range of services focus on investigating physico-chemical properties of primary packaging materials and components and studying the interactions between container closure systems and drugs.
Stevanato Group supplies drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and life sciences industries.
Stevanato Group offers contract manufacturing services for companies with complex drug delivery programmes.
Stevanato Group offers solutions and services for the diagnostic and healthcare sectors, with a focus on high-precision medical products.
Stevanato Group's Technology Excellence Centre in Boston, Massachusetts, allows us to support clients at all stages of drug development.